2 recruiting, 2 unknown, 1 completed. 4 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 2, Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Yangxinshi: new trials by email Literature Review of Yangxinshi trials Research Report on Yangxinshi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction Yangxinshi tablet, Blank control - Coronary Heart Disease, Cardiac Dysfunction | Phase 4 | Recruiting | SPH Qingdao Growful Pharmacetical Co.,Ltd | 2708 | 2025-11-06 | 2025-11-25 |
| Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome Yangxinshi tablet, Basic medication - Chronic Coronary Syndrome | Phase 4 | Recruiting | Shandong First Medical University | 1200 | 2023-12-18 | 2024-04-17 |
| Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY） Yangxinshi tablet, Yangxinshi tablet simulants - Chronic Coronary Syndrome | Phase 4 | Unknown | Dongzhimen Hospital, Beijing | 120 | 2023-11-08 | 2023-12-18 |
| Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI Yangxinshi, Trimetazidine, Yangxinshi mimic - Percutaneous Coronary Intervention | Phase 4 | Completed | Shenyang Northern Hospital | 681 | 2019-08-01 | 2025-09-10 |
| Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease Yangxinshi pill, conventional coronary heart disease medicine, Placebos - Coronary Heart Disease | Phase 2 | Unknown | Affiliated Hospital of Changchun University of Chinese Medicine | 90 | 2017-06-01 | 2018-03-27 |
Coronary Disease (2)
Affiliated Hospital of Changchun University of Chinese Medicine (1) · Dongzhimen Hospital, Beijing (1) · SPH Qingdao Growful Pharmacetical Co.,Ltd (1) · Shandong First Medical University (1) · Shenyang Northern Hospital (1)
China (5)
Wang Xian (1) · Xiaoping Meng, Doctor (1) · Yuan Haitao (1)